Dopamine and serotonin transporter availability in chronic heroin users: A [123I]β-CIT SPECT imaging study

[1]  J. Ott,et al.  Genetic susceptibility to heroin addiction: a candidate gene association study , 2008, Genes, brain, and behavior.

[2]  Yuanye Ma,et al.  Extremely low-frequency electromagnetic field exposure during chronic morphine treatment strengthens downregulation of dopamine D2 receptors in rat dorsal hippocampus after morphine withdrawal , 2008, Neuroscience Letters.

[3]  Li-yan Zhao,et al.  PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. , 2008, European journal of pharmacology.

[4]  J. Bobes,et al.  Association between Heroin Dependence and 5-HT2A Receptor Gene Polymorphisms , 2008, European Addiction Research.

[5]  Z. Wu,et al.  Neuroimaging studies of brain corpus striatum changes among heroin‐dependent patients treated with herbal medicine, U'finer ™ capsule , 2005, Addiction biology.

[6]  G. Gerra,et al.  Neuroendocrine correlates of antisocial personality disorder in abstinent heroin‐dependent subjects , 2003, Addiction biology.

[7]  M Fujita,et al.  Sex differences in [123I]β‐CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers , 2001, Synapse.

[8]  J. Haycock,et al.  Striatal Dopaminergic and Serotonergic Markers in Human Heroin Users , 2001, Neuropsychopharmacology.

[9]  A. Heinz,et al.  Serotonergic dysfunction in addiction: effects of alcohol, cigarette smoking and heroin on platelet 5-HT content , 1997, Psychiatry Research.

[10]  P B Hoffer,et al.  Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  P. Enrico,et al.  Effects of morphine treatment and withdrawal on striatal and limbic monoaminergic activity and ascorbic acid oxidation in the rat , 1996, Brain Research.

[12]  J. Seibyl,et al.  Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  R. Wise,et al.  Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self‐administration , 1995, Synapse.

[14]  Robert B. Innis,et al.  Graphical, Kinetic, and Equilibrium Analyses of in vivo [123I]β-CIT Binding to Dopamine Transporters in Healthy Human Subjects , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  S. Zoghbi,et al.  Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil. , 1994, Journal of pharmaceutical sciences.

[16]  R. Simantov.  Chronic morphine alters dopamine transporter density in the rat brain: Possible role in the mechanism of drug addiction , 1993, Neuroscience Letters.

[17]  Robert B. Innis,et al.  Evaluation of the monoamine uptake site ligand [131I]methyl 3β-(4-Iodophenyl)-tropane-2β-carboxylate ([123I]β-CIT) in non-human primates: Pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI , 1993 .

[18]  Marc Laruelle,et al.  SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primates , 1993, Synapse.

[19]  M Laruelle,et al.  Regional distribution of serotonergic pre‐ and postsynaptic markers in human brain , 1989, Acta psychiatrica Scandinavica. Supplementum.

[20]  J. Marcusson,et al.  High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue , 1989, Brain Research.

[21]  Marc Laruelle,et al.  Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites , 1988, Biological Psychiatry.

[22]  G. Di Chiara,et al.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[23]  U. Spampinato,et al.  Dopamine receptor subsensitivity in the substantia nigra after chronic morphine treatment in rats. , 1988, European journal of pharmacology.

[24]  U. Spampinato,et al.  Changes of serotonin and dopamine metabolism in various forebrain areas of rats injected with morphine either systemically or in the raphe nuclei dorsalis and medianus , 1985, Brain Research.